MJ

Mark Jelley

Partner at OrbiMed Advisors

New York, New York

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $1,000,000.00

  • Max Investment:

    $75,000,000.00

  • Target Investment:

    $4,000,000.00

Skills

Venture Capital
Financial Modeling
Valuation
Investment Banking
Start-ups
Leveraged Finance
Private Equity
Management
Capital Markets

Education

Lists including Mark

AM
AR
AG
AH

Based in NYC

2599 people

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

Caris Life Sciences

Debt Financing

Total Funding: $400M

DarioHealth

Post Ipo Debt

Total Funding: $50M

Work Experience

OA
OrbiMed Advisors

2012

  • Partner

    2012

    OrbiMed invests across the global healthcare industry, from seed-stage venture capital to large publicly-traded companies.

CL
Caris Life Sciences

2020 - 2025

  • Board Observer

    2020 - 2025

V
Valneva

2020 - 2024

  • Board Observer

    2020 - 2024

A
AbCellera

2020 - 2020

  • Board Observer

    2020 - 2020

GH
Guardant Health

2016 - 2018

  • Board Observer

    2016 - 2018

HT
HLS Therapeutics Inc.

2015 - 2017

  • Board Member

    2015 - 2017

N
Natera

2012 - 2015

  • Board Observer

    2012 - 2015

UI
UBS Investment Bank

2010 - 2012

  • Financial Sponsors and Leveraged Finance Group

    2010 - 2012

MG
Macquarie Group

2008 - 2010

  • Analyst, Principal Investing

    2008 - 2010